CYP2C8 Polyclonal Antibody

CYP2C8 encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize many xenobiotics, including the anticonvulsive drug mephenytoin, benzo(a)pyrene, 7-ethyoxycoumarin, and the anti-cancer drug taxol. This gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. Several transcript variants encoding a few different isoforms have been found for this gene.

The CYP2E1 Polyclonal Antibody is a highly specific and sensitive tool for the detection and quantification of the cytochrome P450 2E1 (CYP2E1) protein. This antibody is produced using a polyclonal approach, which ensures a high degree of specificity and sensitivity for the target protein. The CYP2E1 Polyclonal Antibody is suitable for use in a variety of applications, including Western blotting, immunohistochemistry, and immunofluorescence.

This antibody is designed to recognize the CYP2E1 protein in a variety of species, including human, mouse, and rat. It has been extensively validated for its specificity and sensitivity, ensuring reliable and reproducible results. The CYP2E1 Polyclonal Antibody is supplied in a convenient format, with a concentration of 1 mg/mL, allowing for easy and efficient use in a variety of experimental settings.

In summary, the CYP2E1 Polyclonal Antibody is a highly specific and sensitive tool for the detection and quantification of the CYP2E1 protein. Its versatility and reliability make it an ideal choice for researchers in a variety of fields, including pharmacology, toxicology, and biochemistry.